세계의 제세동기 시장 규모는 2023년에 101억 9,000만 달러, 2030년까지 122억 4,000만 달러에 달하며, 2024-2030년의 예측 기간에 CAGR로 3.11%의 성장이 전망됩니다. 제세동기에 대한 수요는 주로 심장병 발병률 증가, 첨단 기술 통합, 정부 및 민간 제조업체의 투자 증가, 심혈관 질환 및 제세동기 사용에 대한 의식의 향상 프로그램 등 증가와 관련이 있습니다.
세동제세동기 시장 역학
심방세동은 불규칙하고 빠른 심박수를 특징으로 하며, 고령자나 고혈압, 비만, 심장병과 같은 만성질환을 앓고 있는 사람들에게 뇌졸중, 심부전 및 기타 심장 관련 합병증 위험을 증가시킬 수 있습니다. 부정맥이며, 2017년 전 세계 심방세동 발생 건수는 304만 6,000건으로 기록되었습니다. 또한 WHO의 2022년 보고서에 따르면 심혈관 질환으로 인한 사망의 85%는 심장마비와 뇌졸중으로 인한 것입니다. 제세동기는 심장에 전기 충격을 보내 정상적인 심장 박동을 회복시키는 장비로 부정맥을 교정하거나 예방하는 데 사용됩니다. 따라서 심장 관련 질환의 발병률 증가는 제세동기에 대한 수요를 불러일으킬 가능성이 높습니다.
또한 간소화된 이식 기술, 소형화, 심장에 이식되는 리드선을 줄이거나 제거한 새로운 기기의 도입도 제세동기 시장을 강화할 것으로 예상됩니다. 예를 들어 2019년에 Biotronik은 새로운 ICD 및 심장 재동기화 치료 제세동기(CRT-D)의 Acticor 장비 제품군을 출시했으며, 하이브리드 ICD Acticor 시스템은 심방 리드 없이도 듀얼 챔버 진단을 제공합니다.
그러나 갑작스런 심장마비에 대한 조기 시정 조치에 대한 인식 부족과 같은 특정 요인이 제세동기 시장 성장에 작은 장애물이 될 것으로 예상됩니다.
제세동기 시장 부문별 분석
제품 유형별 제세동기 시장에서는 ICD(이식형 제세동기)가 가장 큰 시장 점유율을 차지할 것으로 예상되며, ICD에는 원챔버형, 듀얼챔버형, 피하 ICD, 자기공명영상(MRI) 안전 ICD 등 다양한 유형이 있습니다. 예를 들어 제세동기 분야에서 최근 개발된 S-ICD는 기존 ICD나 경정맥 ICD에 비해 많은 장점을 가지고 있습니다. 주요 장점으로는 혈관 손상 및 기흉의 위험이 낮고, 리드선이 없어 선천성 심장 질환이 있는 소아 및 정맥을 통해 ICD를 삽입할 수 없는 환자에게 적합하다는 점 등을 들 수 있습니다. 또한 이 장비는 기존 경정맥 ICD보다 내약성이 우수하여 향후 수년간 ICD에 대한 수요를 증가시킬 것으로 예상됩니다.
또한 규제 당국의 신제품 승인도 시장을 빠르게 성장시킬 것으로 예상됩니다. 예를 들어 최근 2018년 Abbott는 Quadra Assura MP CRT-D와 Fortify Assura ICD의 MR 조건부 적응증에 대한 FDA 승인을 받았습니다. 또한 가장 널리 사용되는 ICD 및 관련 고전압 리드 중 하나인 Ellipse ICD에 대한 MR 조건부 라벨링에 대한 FDA 승인을 받았습니다. 따라서 최근 주요 기업의 필수 의료기기 제조 증가와 함께 최근 제품 승인은 제세동기 시장 성장에 기여할 것으로 예상됩니다.
북미가 전체 제세동기 시장을 독점할 것으로 예상됩니다.
모든 지역 중 북미가 예측 기간 중 전체 제세동기 시장을 독점할 것으로 예상됩니다. 이는 심혈관 질환의 유병률 증가, 더 나은 의료 인프라에 대한 접근성, 이 지역의 주요 시장 기업의 존재에 기인합니다. 또한 이식형 장비 비용과 시술에 대한 보조금 지원 프로그램도 이 지역에서 이식형 장비를 선택하는 사람들을 더욱 부추기고 있습니다.
또한 미국에서는 심혈관 질환에 걸릴 위험이 급격히 증가하고 있으며, CDC에 따르면 2020년 심장병은 미국 대부분의 남녀의 사망 원인 1위이며, 미국에서는 매년 약 65만 5,000명의 미국인이 심장병으로 사망하고 있습니다. 이 지역의 심혈관 질환에 대한 관심이 높아짐에 따라 시장이 성장할 것으로 예상됩니다. 또한 Stryker, Abbott, Boston Scientific Corporation 등 주요 업체들의 ICD 및 체외 제세동기 분야에서의 제휴, 제품 출시, 인수합병 등 다양한 상업화 활동으로 인해 시장이 빠르게 성장할 것으로 예상되며, 이는 이 지역 시장을 활성화시킬 것으로 전망됩니다. 이 지역 시장을 활성화시킬 것으로 예상됩니다.
세계의 제세동기 시장에 대해 조사분석했으며, 시장 규모와 예측, 촉진요인과 과제, 기업과 제품 개요 등을 제공하고 있습니다.
Defibrillators Market By Product Type (Implantable Cardioverter Defibrillator [Single Chamber ICD, Dual Chamber ICD, CRT-D, Subcutaneous ICD (S-ICD)], and External Defibrillator [Semi-Automated, Automated, and Wearable]), End-User (Hospitals, Ambulatory Surgical Centres, Homecare Settings, and Others), Geography is projected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of cardiac disorders and integration of advanced technology
Global Defibrillators Market was valued at USD 10.19 billion in 2023, growing at a CAGR of 3.11% during the forecast period from 2024 to 2030, to reach USD 12.24 billion by 2030. The demand for defibrillators is primarily associated with the growing incidence of cardiac disorders, integration of advanced technology, increasing investments by government and private manufacturers, and rising awareness programs regarding cardiovascular disorders and the usage of defibrillators, among others.
Defibrillators Market Dynamics:
Atrial fibrillation which is characterized by an irregular and most often rapid heart rate can increase the risk of stroke, heart failure, and other heart-related complications in the old aged population and individuals suffering chronic conditions such as high blood pressure, obesity, and heart disorders. According to a study published in NCBI 2022, atrial fibrillation is the most frequent cardiac arrhythmia, and the worldwide incidence of atrial fibrillation in 2017 was registered to be 3.046 million. Moreover, as per the WHO 2022 report, 85% of all cardiovascular deaths are due to heart attacks and stroke. Defibrillators are devices used to restore a normal heartbeat by sending an electric shock to the heart and are used to correct or prevent arrhythmias. Therefore, the rising incidence of heart-associated disorders is likely to shoot the demand for defibrillators.
Further, the introduction of several new devices with simplified implantation technology, smaller size, and reducing or eliminating leads implanted in the heart is also anticipated to augment the market for defibrillators. For instance, in 2019, Biotronik launched the Acticor device family of new ICDs and cardiac resynchronization therapy defibrillators (CRT-Ds), the hybrid ICD Acticor systems offer dual-chamber diagnostics without the need for an atrial lead.
However, certain factors such as lack of awareness regarding early corrective measures for sudden cardiac arrest are anticipated to pose a minor hurdle for the growth of the defibrillators market.
Defibrillators Market Segment Analysis:
Defibrillator Market By Product Type (Implantable Cardioverter Defibrillator [Single Chamber ICD, Dual Chamber ICD, CRT-D, Subcutaneous ICD (S-ICD)], and External Defibrillator [Semi-Automated, Automated, and Wearable]), End-User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Defibrillators product type segment, ICD (Implantable Cardioverter Defibrillator) is expected to hold the largest share in the market as there are different types of ICDs such as one-chambered, dual-chambered ICDs, subcutaneous ICDs, and magnetic resonance imaging (MRI)-safe ICDs available in the market. For instance, S-ICDs which are a recent development in the field of defibrillators have many advantages over traditional or transvenous ICDs. These mainly include lower risk of vascular injury or pneumothorax, the absence of leads is the main advantage making it a great alternative for children with congenital heart diseases or patients with no venous access who were unsuitable for transvenous ICD. Also, the device is more well tolerated than the traditional (transvenous) ICDs thereby raising the demand for ICDs in the coming years.
In addition, new product approvals in the market by regulatory bodies are also expected to surge the market. For instance, recently in the year 2018, Abbott received FDA approval for the MR-conditional labeling for the Quadra Assura MP CRT-D and Fortify Assura ICD. Moreover, the same company has received FDA clearance for MR-conditional labeling for one of the company's most widely used ICDs and associated high-voltage leads - the Ellipse ICD. Therefore, recent product approvals along with increased manufacturing of essential medical devices by key players are the factors expected to contribute to the defibrillators market growth.
North America is expected to dominate the overall Defibrillators Market:
Among all the regions, North America is expected to dominate the overall Defibrillator market during the forecast period. This domination is due to the growing prevalence of cardiovascular diseases, access to better healthcare infrastructure coupled with the presence of major market players in the region. Also, the supportive reimbursement programs covering the costs for the implantable devices as well as the procedure further encouraged people to opt for such devices in the region.
Further, in the United States, the risk of being affected by cardiovascular disease is increasing dramatically. According to the CDC, in 2020, heart disease was the leading cause of death among most men and women in the United States and about 655,000 Americans died from heart disease each year in the region. The rising concern about cardiovascular disorders in the region is expected to boost the market. Furthermore, the presence of key manufacturers in the region such as Stryker, Abbott, and Boston Scientific Corporation, among others in the region will surge the market due to various commercialization activities including collaborations, product launches, merger acquisitions, and others in the field of both ICDs and External defibrillator is projected to fuel the market in the region. For instance, in 2019, Stryker launched LIFEPAK® CR2 Defibrillator with LIFELINK central(TM) AED Program Manager in the United States. Moreover, the rising installation of external defibrillators in public places apart from hospitals aiming to prevent sudden cardiac arrest is also a prominent factor contributing to the market growth. Hence, all these factors along with product launches are propelling the defibrillators market.
Europe and Asia-Pacific region have a future potential growth in the global defibrillators market. This is due to the rising burden of cardiovascular diseases in the European region countries and Asia countries also. The rising healthcare costs, improving healthcare infrastructure, and increase in disposable income in growing economies such as China, and India, among others are other factors that boost the market. In addition, countries such as Japan have a high penetration of defibrillators due to the presence of giant companies that are focused on expanding the market in other geographies is also likely to augment the global defibrillators market.
Defibrillators Market Key Players:
Some of the key market players operating in the Defibrillator market include Medtronic; Abbott; Boston Scientific Corporation; Stryker; Koninklijke Philips N.V.; Zoll Medical Corporation; Biotronik, Inc.; Nihon Kohden Corporation, and others.
Recent Developmental Activities in Defibrillators Market:
In July 2020, Phillips received 510(k) clearances from the FDA for its professional defibrillator (Tempus LS- Manual), offering its remote monitor and defibrillator solution (Tempus ALS) to EMS customers in the U.S.
In June 2020, ZOLL® Medical Corporation, an Asahi Kasei Group Company received premarket approval (PMA) for its ZOLL AED 3® defibrillator with enhanced real CPR help, integrated child rescue, and wireless connectivity.
In February 2020, Abbott received CE Mark for the new Gallant(TM) implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) devices. The devices offer new opportunities for patient engagement and remote monitoring through new smartphone connectivity and connected applications. Additional benefits include a patient-preferred design, improved battery longevity, and MRI compatibility.
Key Takeaways from the Defibrillators Market Report Study
Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Defibrillators market.
Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the Global Defibrillators Market.
Various opportunities available for the other competitor in the Defibrillators Market space.
What are the top-performing segments in 2023? How these segments will perform in 2030?
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Defibrillators market growth in the coming future?
Target Audience who can be benefited from Defibrillators Market Report Study
Defibrillators providers
Research organizations and consulting companies
Defibrillators-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Defibrillators
Various End-users who want to know more about the Defibrillators Market and the latest technological developments in the Defibrillators market.
Frequently Asked Questions for Defibrillators Market:
What are Defibrillators?
Defibrillators are devices that give a high-energy electric shock to the heart of an individual who suffers a cardiac arrest. These can be implantable, external, and wearable based on their modality.
What is the market for Global Defibrillators?
Global Defibrillator Market was valued at USD 10.19 billion in 2023, growing at a CAGR of 3.11% during the forecast period from 2024 to 2030, to reach USD 12.24 billion by 2030.
What are the drivers for Global Defibrillators Market?
The major factors responsible for driving the defibrillators market are the increasing prevalence of cardiac disorders, growing public-private investment in developing new and technologically advanced products, and rising awareness associated with defibrillators in cardiac-associated diseases in many countries.
What are the key players operating in Global Defibrillators Market?
Some of the key market players operating in the Defibrillator market include Medtronic; Abbott; Boston Scientific Corporation; Stryker; Koninklijke Philips N.V.; Zoll Medical Corporation; Biotronik, Inc.; Nihon Kohden Corporation, and others.
What region has the highest share in the Defibrillators market?
North America is expected to dominate the overall Defibrillator market during the forecast period, 2024-2030 owing to the growing prevalence of cardiovascular diseases, access to improved healthcare infrastructure coupled with the presence of major market players in the region. Moreover, enhanced reimbursement programs for the implantable devices as well as the procedure further encouraged people to opt for such devices in the region.